GSE161800
Pulsed cisplatin treatment of A549 lung adenocarcinoma cells
A549 lung adenocarcinoma cells were pulsed for 2h with cisplatin and allowed to recover for 3 days. Cells were then FACS sorted based on size and enriched populations analysed for RNAseq. Overall design: Next-generation RNAseq analysis of cisplatin pulsed A549 lung adenocarcinoma cells pre and post FACS sorting for cell size, in biological triplicate.